Hyperpigmentation has become one of the most-requested concerns in aesthetic dermatology, yet it’s also one of the most persistently challenging to treat. Melasma, post-inflammatory hyperpigmentation (PIH) and stubborn dark spots all demand precision, patience and a deep understanding of how pigment really behaves in the skin.

On March 25, Beverly Hills–based Board-Certified dermatologist Dr. Haleh Bakshandeh(@drbdermatology) will lead a live MDPen webinar on how Corrective Microneedling™ can be leveraged to address hyperpigmentation more safely and effectively—especially in skin tones that are traditionally harder to treat.

The pigment puzzle: melasma vs. PIH

While hyperpigmentation is often discussed as a single category, melasma and PIH are distinct clinical entities that respond differently to treatment. Melasma is typically chronic and hormonally influenced, strongly tied to UV exposure and heat, while PIH is triggered by inflammation—think acne, eczema flares, procedural injury or irritation.

What they share is melanocyte overactivity: once those pigment-producing cells are overstimulated, they can remain “on” long after the initial trigger, leaving behind persistent uneven tone and a high risk of recurrence if treatment isn’t carefully calibrated.

Why traditional microneedling isn’t always enough

Classic microneedling is loved for collagen stimulation, texture refinement and overall rejuvenation, but when hyperpigmentation and higher Fitzpatrick types enter the picture, “more injury” is not always “more results.”

Excess or uncontrolled inflammation can actually worsen PIH or destabilize melasma, which is why Corrective Microneedling™ shifts the focus from simple injury to intentional, measured micro-injury designed with pigment-prone skin in mind.

What makes Corrective Microneedling™ different

Corrective Microneedling™  centers on three key variables: microchannel density, depth precision and technique control. By tailoring these parameters, practitioners can influence how keratinocytes, fibroblasts and melanocytes interact during the healing cascade.

The goal is to stimulate epidermal renewal and dermal remodeling while minimizing unnecessary inflammatory signals that drive pigment rebound, supporting more even tone and longer-lasting clarity for melasma- and PIH-prone patients.

Regulation, renewal and dermal remodeling

At the cellular level, carefully controlled microchannels create a therapeutic window: enough disruption to signal regeneration, but not so much that the skin’s response becomes chaotic. This balance helps normalize melanocyte behavior, improve barrier function and support healthier collagen architecture.

When paired with appropriate topical regimens and strict photoprotection, this corrective approach to microneedling can integrate seamlessly into a comprehensive hyperpigmentation protocol rather than acting as a standalone “fix.”

Treating Fitzpatrick IV–VI with confidence

For patients with Fitzpatrick IV–VI skin, the stakes around inflammation and pigment are especially high, yet demand for in-office procedures continues to grow.  

During the webinar, Dr. Bakshandeh will share how to adjust settings, spacing, pre- and post-care, and treatment cadence to respect melanin-rich skin while still targeting texture, tone and acne-related PIH.

What attendees will learn

This session is designed for aesthetic providers and advanced skincare enthusiasts who want a deeper, clinically grounded understanding of microneedling for hyperpigmentation. You’ll gain:

• • Clinical considerations when differentiating and treating melasma versus PIH
    
  • Safe treatment strategies for Fitzpatrick IV–VI patients, including ways to reduce treatment-induced PIH risk
    
  • How Corrective Microneedling™ can support melanocyte regulation, skin tone normalization and long-term maintenance
    
  • Practical protocol insights and real-world pearls from Dr. Bakshandeh

Join the live conversation

Corrective Microneedling™ in the Treatment of Hyperpigmentation

• Date: March 25 at 8:00pm EDT
• Speaker:Dr. Haleh Bakshandeh, Board-Certified Dermatologist, Beverly Hills, CA
• Who it’s for: licensed Medical aesthetic practitioners and professionals 

Reserve your spot to explore how a corrective, physiology-respecting approach to microneedling can transform the way you treat— and talk about—hyperpigmentation.

FAQs

Is Corrective Microneedling™ safe for melasma?

Corrective Microneedling™ can be incorporated into a melasma treatment plan when protocols are tailored to minimize heat and inflammation, and when strict sun protection and pigment-regulating topicals are part of the overall regimen. It’s not a one-and-done cure, but a controlled tool within a broader strategy.

How is treating PIH different from treating melasma?

PIH is a post-injury pigment response, so the focus is on reducing ongoing inflammation, supporting barrier repair and avoiding additional trauma, whereas melasma behaves more like a chronic condition with hormonal and environmental drivers. In practice, that often means PIH can respond more predictably to Corrective Microneedling™ when the trigger is controlled and post-care is meticulous.

What about Fitzpatrick IV–VI—can microneedling worsen hyperpigmentation?

Any procedure that induces inflammation can worsen hyperpigmentation in melanin-rich skin if performed too aggressively or without proper prep and aftercare. Corrective Microneedling™ protocol emphasizes calibrated depth, controlled microchannel density and conservative treatment planning to support collagen and tone without tipping into rebound PIH.

How much downtime should patients expect?

Most patients experience transient erythema and mild sensitivity for 24–72 hours, with some dryness or flaking as the epidermis renews. Downtime can vary based on settings and skin type, but the goal with Corrective Microneedling™ is to keep recovery in the “socially acceptable” range while still activating meaningful remodeling.

Can Corrective Microneedling™ be combined with other treatments?

Yes—many practices layer Corrective Microneedling™ with pigment-balancing topicals, antioxidant serums and gentle chemical exfoliants as part of a staged protocol. Timing and sequencing matter; in the webinar, Dr. Bakshandeh will discuss how to integrate microneedling into comprehensive plans without overwhelming the skin.

Who is not a good candidate?

Patients with uncontrolled inflammatory conditions, active infections, impaired wound healing or unrealistic expectations may not be ideal candidates. Careful consultation, medical history review and sometimes pre-conditioning are essential before proceeding with any corrective microneedling approach.